WO2001090124A3 - Haplotypes du gene gpr31 - Google Patents

Haplotypes du gene gpr31 Download PDF

Info

Publication number
WO2001090124A3
WO2001090124A3 PCT/US2001/016908 US0116908W WO0190124A3 WO 2001090124 A3 WO2001090124 A3 WO 2001090124A3 US 0116908 W US0116908 W US 0116908W WO 0190124 A3 WO0190124 A3 WO 0190124A3
Authority
WO
WIPO (PCT)
Prior art keywords
haplotypes
gpr31
gene
disclosed
gpr31 gene
Prior art date
Application number
PCT/US2001/016908
Other languages
English (en)
Other versions
WO2001090124A2 (fr
Inventor
Karyn M Bieglecki
Amy Duda
Amir Kazemi
Helen H Lee
Chad Messer
Original Assignee
Genaissance Pharmaceuticals
Karyn M Bieglecki
Amy Duda
Amir Kazemi
Helen H Lee
Chad Messer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Karyn M Bieglecki, Amy Duda, Amir Kazemi, Helen H Lee, Chad Messer filed Critical Genaissance Pharmaceuticals
Priority to AU2001264938A priority Critical patent/AU2001264938A1/en
Publication of WO2001090124A2 publication Critical patent/WO2001090124A2/fr
Publication of WO2001090124A3 publication Critical patent/WO2001090124A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La présente invention concerne de nouvelles variantes génétiques du gène du récepteur 31 couplé à la protéine G (GPR31). Par ailleurs, cette invention concerne divers génotypes, haplotypes, et paires d'haplotypes du gène GPR31 existant dans la population générale américaine. Cette invention concerne également des compositions et des méthodes d'haplotypage et/ou de génotypage du gène GPR31 chez un individu. Enfin, cette invention concerne des polynucléotides définis par la séquence des haplotypes précités.
PCT/US2001/016908 2000-05-23 2001-05-23 Haplotypes du gene gpr31 WO2001090124A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001264938A AU2001264938A1 (en) 2000-05-23 2001-05-23 Haplotypes of the gpr31 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20657200P 2000-05-23 2000-05-23
US60/206,572 2000-05-23

Publications (2)

Publication Number Publication Date
WO2001090124A2 WO2001090124A2 (fr) 2001-11-29
WO2001090124A3 true WO2001090124A3 (fr) 2002-03-14

Family

ID=22766970

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/016908 WO2001090124A2 (fr) 2000-05-23 2001-05-23 Haplotypes du gene gpr31

Country Status (2)

Country Link
AU (1) AU2001264938A1 (fr)
WO (1) WO2001090124A2 (fr)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION. NATIONAL LIBRARY OF MEDICINE, NIH (BETHESDA, MD, USA); July 1996 (1996-07-01), ZINGONI A. ET AL., XP002949227, accession no. NCBI Database accession no. HSU65402 *
SOURCE GENOMICS, vol. 42, no. 3, 1997, pages 519 - 523 *
ZINGONI A. ET AL.: "Isolation and chromosomal localization of GPR31, a human gene encoding a putative G protein-coupled receptor", GENOMICS, vol. 42, 1997, pages 519 - 523, XP002949226 *

Also Published As

Publication number Publication date
WO2001090124A2 (fr) 2001-11-29
AU2001264938A1 (en) 2001-12-03

Similar Documents

Publication Publication Date Title
WO2001090122A3 (fr) Haplotypes du gene ctla4
WO2002026764A3 (fr) Haplotypes du gene ccr6
WO2002008425A3 (fr) Haplotypes du gene adrb3
WO2001090128A3 (fr) Haplotypes du gene gpr3
WO2002006446A3 (fr) Haplotypes du gene edg6
WO2001090124A3 (fr) Haplotypes du gene gpr31
WO2001087904A3 (fr) Haplotypes du gene gpr4
WO2002020556A3 (fr) Haplotypes du gene gpr68
WO2002050098A3 (fr) Haplotypes du gene du recepteur de la prolactine (prlr)
WO2002038587A3 (fr) Haplotypes du gene grm8
WO2002026766A3 (fr) Haplotypes du gene sstr4
WO2002032928A3 (fr) Haplotypes du gene hrh1
WO2002016399A3 (fr) Haplotypes du gene tacr1
WO2001087908A3 (fr) Haplotypes du gene ccr3
WO2001096350A3 (fr) Haplotypes du gene grm3
WO2001090118A3 (fr) Haplotypes du gene edn2
WO2001087909A3 (fr) Haplotypes du gene aanat
WO2002032924A3 (fr) Haplotypes du gene chrm5
WO2002002580A3 (fr) Haplotypes du gene etfb
WO2002012561A3 (fr) Haplotypes du gene or1g1
WO2002026770A3 (fr) Haplotypes du gene admr
WO2002090378A3 (fr) Haplotypes du gene de ces2
WO2002036609A3 (fr) Haplotypes du gene chrm4
WO2001092278A3 (fr) Haplotypes du gene rlbp1
WO2002051859A3 (fr) Haplotypes du gene ptafr

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP